< Back to previous page

Project

PRISMA:Polygenic Risc scoring and deep-Immunophenotyping Strategy to Master Alzheimer's disease (PRISMA)

The consortium is committed to pushing Alzheimer's disease (AD) towards personalized medicine. This project will broaden and deepen the knowledge about genetic risk and immune biomarkers for AD. She will also build a solid data platform that can be used to rigorously recruit stratified populations for clinical studies and serve as a basis for designing personalized diagnostic applications and targeted interventions for AD. The central hypothesis is that an individual polygenic risk score (PRS) can be directly translated into specific pathways that can initiate and propel AD.

Date:1 Mar 2020 →  28 Feb 2023
Keywords:Alzheimer's disease, Polygenic Risc Scoring, deep-immunophenotyping strategy
Disciplines:Neurological and neuromuscular diseases